APO RESEARCH · REPORT
Atrial Fibrillation Surgery Devices
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF
Product & engineering
Understand the product.
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF
Selected research
Industry Research
Atrial Fibrillation Surgery Devices Industry Research Report 2026
Market perspective
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF
In terms of region, the largest segment of Atrial Fibrillation Surgery Devices Market would be North America, with a market share of over 40％ in 2019. The follower is Europe accounted for nearly 27％ of global market.
For the major players of Atrial Fibrillation Surgery Devices, Johnson & Johnson maintained its first place in the ranking in 2019. Followed by Abbott，Medtronic，Japan Lifeline，Boston Scientific etc.. The Top 5 players accounted for about 86％ of the Atrial Fibrillation Surgery Devices revenue market share in 2019.
Read the full market overview
Report Scope
This report quantifies the global Atrial Fibrillation Surgery Devices market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Atrial Fibrillation Surgery Devices Market by Company
Johnson & Johnson
Abbott
Medtronic
Japan Lifeline
Boston Scientific
Atricure
Biotroik
OSYPKA AG
Cardiofocus
MicroPort EP MedTech
Synaptic Medical
Atrial Fibrillation Surgery Devices Segment by Type
Catheter Ablation
Maze Surgery
Atrial Fibrillation Surgery Devices Segment by Application
Hospitals
Ambulatory Surgical Centers
Atrial Fibrillation Surgery Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atrial Fibrillation Surgery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atrial Fibrillation Surgery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atrial Fibrillation Surgery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Atrial Fibrillation Surgery Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Atrial Fibrillation Surgery Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Atrial Fibrillation Surgery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Catheter Ablation
- Maze Surgery
Applications
- Hospitals
- Ambulatory Surgical Centers
Companies covered
- Johnson & Johnson
- Abbott
- Medtronic
- Japan Lifeline
- Boston Scientific
- Atricure
- Biotroik
- OSYPKA AG
- Cardiofocus
- MicroPort EP MedTech
- Synaptic Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Atrial Fibrillation Surgery Devices Market Size (2021-2032)
- 2.2.2 Global Atrial Fibrillation Surgery Devices Sales (2021-2032)
- 2.2.3 Global Atrial Fibrillation Surgery Devices Market Average Price (2021-2032)
- 2.3 Atrial Fibrillation Surgery Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Catheter Ablation
- 2.3.3 Maze Surgery
- 2.4 Atrial Fibrillation Surgery Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Ambulatory Surgical Centers
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Atrial Fibrillation Surgery Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Atrial Fibrillation Surgery Devices Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Atrial Fibrillation Surgery Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Atrial Fibrillation Surgery Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Atrial Fibrillation Surgery Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Atrial Fibrillation Surgery Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Atrial Fibrillation Surgery Devices, Product Type & Application
- 3.8 Global Manufacturers of Atrial Fibrillation Surgery Devices, Established Date
- 3.9 Global Atrial Fibrillation Surgery Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Atrial Fibrillation Surgery Devices Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Abbott
- 4.2.1 Abbott Company Information
- 4.2.2 Abbott Business Overview
- 4.2.3 Abbott Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Abbott Atrial Fibrillation Surgery Devices Product Portfolio
- 4.2.5 Abbott Recent Developments
- 4.3 Medtronic
- 4.3.1 Medtronic Company Information
- 4.3.2 Medtronic Business Overview
- 4.3.3 Medtronic Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Medtronic Atrial Fibrillation Surgery Devices Product Portfolio
- 4.3.5 Medtronic Recent Developments
- 4.4 Japan Lifeline
- 4.4.1 Japan Lifeline Company Information
- 4.4.2 Japan Lifeline Business Overview
- 4.4.3 Japan Lifeline Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Japan Lifeline Atrial Fibrillation Surgery Devices Product Portfolio
- 4.4.5 Japan Lifeline Recent Developments
- 4.5 Boston Scientific
- 4.5.1 Boston Scientific Company Information
- 4.5.2 Boston Scientific Business Overview
- 4.5.3 Boston Scientific Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Boston Scientific Atrial Fibrillation Surgery Devices Product Portfolio
- 4.5.5 Boston Scientific Recent Developments
- 4.6 Atricure
- 4.6.1 Atricure Company Information
- 4.6.2 Atricure Business Overview
- 4.6.3 Atricure Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Atricure Atrial Fibrillation Surgery Devices Product Portfolio
- 4.6.5 Atricure Recent Developments
- 4.7 Biotroik
- 4.7.1 Biotroik Company Information
- 4.7.2 Biotroik Business Overview
- 4.7.3 Biotroik Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Biotroik Atrial Fibrillation Surgery Devices Product Portfolio
- 4.7.5 Biotroik Recent Developments
- 4.8 OSYPKA AG
- 4.8.1 OSYPKA AG Company Information
- 4.8.2 OSYPKA AG Business Overview
- 4.8.3 OSYPKA AG Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 OSYPKA AG Atrial Fibrillation Surgery Devices Product Portfolio
- 4.8.5 OSYPKA AG Recent Developments
- 4.9 Cardiofocus
- 4.9.1 Cardiofocus Company Information
- 4.9.2 Cardiofocus Business Overview
- 4.9.3 Cardiofocus Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cardiofocus Atrial Fibrillation Surgery Devices Product Portfolio
- 4.9.5 Cardiofocus Recent Developments
- 4.10 MicroPort EP MedTech
- 4.10.1 MicroPort EP MedTech Company Information
- 4.10.2 MicroPort EP MedTech Business Overview
- 4.10.3 MicroPort EP MedTech Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 MicroPort EP MedTech Atrial Fibrillation Surgery Devices Product Portfolio
- 4.10.5 MicroPort EP MedTech Recent Developments
- 4.11 Synaptic Medical
- 4.11.1 Synaptic Medical Company Information
- 4.11.2 Synaptic Medical Business Overview
- 4.11.3 Synaptic Medical Atrial Fibrillation Surgery Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Synaptic Medical Atrial Fibrillation Surgery Devices Product Portfolio
- 4.11.5 Synaptic Medical Recent Developments
5 Global Atrial Fibrillation Surgery Devices Market Scenario by Region
- 5.1 Global Atrial Fibrillation Surgery Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Atrial Fibrillation Surgery Devices Sales by Region: 2021-2032
- 5.2.1 Global Atrial Fibrillation Surgery Devices Sales by Region: 2021-2026
- 5.2.2 Global Atrial Fibrillation Surgery Devices Sales by Region: 2027-2032
- 5.3 Global Atrial Fibrillation Surgery Devices Revenue by Region: 2021-2032
- 5.3.1 Global Atrial Fibrillation Surgery Devices Revenue by Region: 2021-2026
- 5.3.2 Global Atrial Fibrillation Surgery Devices Revenue by Region: 2027-2032
- 5.4 North America Atrial Fibrillation Surgery Devices Market Facts & Figures by Country
- 5.4.1 North America Atrial Fibrillation Surgery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Atrial Fibrillation Surgery Devices Sales by Country (2021-2032)
- 5.4.3 North America Atrial Fibrillation Surgery Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Atrial Fibrillation Surgery Devices Market Facts & Figures by Country
- 5.5.1 Europe Atrial Fibrillation Surgery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Atrial Fibrillation Surgery Devices Sales by Country (2021-2032)
- 5.5.3 Europe Atrial Fibrillation Surgery Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Atrial Fibrillation Surgery Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Atrial Fibrillation Surgery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Atrial Fibrillation Surgery Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Atrial Fibrillation Surgery Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Atrial Fibrillation Surgery Devices Market Facts & Figures by Country
- 5.7.1 South America Atrial Fibrillation Surgery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Atrial Fibrillation Surgery Devices Sales by Country (2021-2032)
- 5.7.3 South America Atrial Fibrillation Surgery Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Atrial Fibrillation Surgery Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Atrial Fibrillation Surgery Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Atrial Fibrillation Surgery Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Atrial Fibrillation Surgery Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Atrial Fibrillation Surgery Devices Sales by Type (2021-2032)
- 6.1.1 Global Atrial Fibrillation Surgery Devices Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Atrial Fibrillation Surgery Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Atrial Fibrillation Surgery Devices Revenue by Type (2021-2032)
- 6.2.1 Global Atrial Fibrillation Surgery Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Atrial Fibrillation Surgery Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Atrial Fibrillation Surgery Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Atrial Fibrillation Surgery Devices Sales by Application (2021-2032)
- 7.1.1 Global Atrial Fibrillation Surgery Devices Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Atrial Fibrillation Surgery Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Atrial Fibrillation Surgery Devices Revenue by Application (2021-2032)
- 7.2.1 Global Atrial Fibrillation Surgery Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Atrial Fibrillation Surgery Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Atrial Fibrillation Surgery Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Atrial Fibrillation Surgery Devices Value Chain Analysis
- 8.1.1 Atrial Fibrillation Surgery Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Atrial Fibrillation Surgery Devices Production Mode & Process
- 8.2 Atrial Fibrillation Surgery Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Atrial Fibrillation Surgery Devices Distributors
- 8.2.3 Atrial Fibrillation Surgery Devices Customers
9 Global Atrial Fibrillation Surgery Devices Analyzing Market Dynamics
- 9.1 Atrial Fibrillation Surgery Devices Industry Trends
- 9.2 Atrial Fibrillation Surgery Devices Industry Drivers
- 9.3 Atrial Fibrillation Surgery Devices Industry Opportunities and Challenges
- 9.4 Atrial Fibrillation Surgery Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst